Results 221 to 230 of about 20,357,001 (365)
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec +6 more
wiley +1 more source
The Role of Ayurveda in Chronic Disease Management: A Review of Clinical Evidence. [PDF]
Karambhe AD +5 more
europepmc +1 more source
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio +8 more
wiley +1 more source
A roadmap for a patient-centred approach to Pompe disease management. [PDF]
Schoser B +7 more
europepmc +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Replaced with revised version of paper 06/08/11.animal compartment model, dairy cattle disease, Johne’s disease, livestock disease control, Mycobacterium avium subspecies paratuberculosis, Farm Management, Livestock Production/Industries,
Grohn, Yrjo T. +5 more
core
The impact of nurse-led care in inflammatory bowel disease management: a systematic review. [PDF]
Wang X +5 more
europepmc +1 more source
Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane +19 more
wiley +1 more source
Turning the tide : the role of water management to prevent legionnaires\u2019 disease
May 21 at 1:00pm ETReports of Legionnaires\u2019 disease (LD) cases and outbreaks are increasing in the United States. LD is a serious lung infection caused by breathing in small water droplets containing Legionella bacteria.
core

